MET kinase-IN-2

For research use only. Not for therapeutic Use.

  • CAT Number: I015152
  • CAS Number: 2101241-90-9
  • Molecular Formula: C33H27FN4O4
  • Molecular Weight: 562.59
Inquiry Now

MET kinase-IN-2(Cat No.:I015152)is a potent small-molecule inhibitor that selectively targets the MET receptor tyrosine kinase, a critical regulator of cell growth, survival, and motility. Aberrant activation of MET signaling is strongly associated with tumor progression, metastasis, and therapeutic resistance in various cancers, including lung, gastric, and renal carcinomas. By blocking MET phosphorylation and downstream pathways such as PI3K/AKT and RAS/MAPK, MET kinase-IN-2 suppresses oncogenic signaling. This compound serves as an important research tool for exploring MET-driven cancers and evaluating novel therapeutic strategies against MET-dependent malignancies.

MET kinase-IN-2 is a potent small-molecule inhibitor that selectively targets the MET receptor tyrosine kinase, a critical regulator of cell growth, survival, and motility. Aberrant activation of MET signaling is strongly associated with tumor progression, metastasis, and therapeutic resistance in various cancers, including lung, gastric, and renal carcinomas. By blocking MET phosphorylation and downstream pathways such as PI3K/AKT and RAS/MAPK, MET kinase-IN-2 suppresses oncogenic signaling. This compound serves as an important research tool for exploring MET-driven cancers and evaluating novel therapeutic strategies against MET-dependent malignancies.

Request a Quote